About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Efficacy of Vaccination Against Diabetes may be Influenced by Seasonal Changes

by Kathy Jones on February 3, 2012 at 8:28 PM
Font : A-A+

 Efficacy of Vaccination Against Diabetes may be Influenced by Seasonal Changes

The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase 3 trials that failed to show significant effects.

One possible explanation may be seasonal variations in the immune system, claim those responsible for the study that was published in the New England Journal of Medicine (NEJM).

Advertisement

At the onset of type 1 diabetes mellitus, the immune system attacks the insulin-producing pancreatic beta-cells. In conjunction with this development antibodies are often directed against different proteins/antigens in the beta-cells. The GAD65 is such an antigen, an enzyme typically present in the brain, however its function in the beta-cells is as yet unknown.

Led by Johnny Ludvigsson, Professor Emeritus of Paediatrics at Linköping University, clinical trials were conducted on the treatment with alum-formulated GAD65 (GAD-alum) for patients with recent-onset type 1 diabetes mellitus. Three years ago, researchers showed in a phase 2 trial that this type of vaccination could retard the degradation of beta-cells. At a four-year follow-up it was established that C-peptide (a measure of endogenous insulin production) was significantly higher in patients who had fallen ill less than six months before the start of the study, compared to that of a control group.
Advertisement

For the phase 3 trial, 334 patients 10 to 20 of age, with type 1 diabetes were recruited. Within three months after diagnosis, patients were randomly assigned to receive one of three study treatments:
  • Four doses of GAD-alum
  • Two doses of GAD-alum followed by two doses of placebo
  • Four doses of placebo

The primary outcome was the change in C-peptide levels 15 months after beginning the treatment. The results showed a positive trend but no significant effect.

The authors of the article in this week's edition of NEJM ask the question: "Why did this phase 3 study show a lack of efficacy, in contrast to our earlier phase 2 study?"

Seasonal variations in the immune system may play a role and have been proposed as one possible explanation. When the material is broken down into subgroups, it appears that the treatment had significant effect among those patients who received their first GAD-alum dose during March or April, which was the period when all patients in the phase 2 trial were vaccinated.

Another discrepancy that may have been significant for the results was that the phase 3 study coincided with the outbreak of the swine influenza epidemic, which led to widespread vaccination. The diabetic patients who were not vaccinated against influenza within 150 days responded better to the GAD-alum treatment than the others in the study. Additional factors affecting the results can be related to age and gender. The effects were significant for boys in the large European phase 3 trial.

The authors write that treatment for type 1 diabetes will probably be based on knowledge gained from this and other studies of single agents or combination therapies. Further analyses are under way addressing, partly the results following a longer follow-up than 15 months, and partly how the immune system responds.

"We have not given up, rather we still believe that the GAD-alum may prove to be an important part of both future prevention and treatment of type 1 diabetes," says Johnny Ludvigsson.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide Silent Killer Diseases 

Most Popular on Medindia

Post-Nasal Drip Drug Side Effects Calculator Pregnancy Confirmation Calculator Hearing Loss Calculator How to Reduce School Bag Weight - Simple Tips Sanatogen Sinopril (2mg) (Lacidipine) Find a Doctor Iron Intake Calculator Calculate Ideal Weight for Infants
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Efficacy of Vaccination Against Diabetes may be Influenced by Seasonal Changes Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests